About IMI
  • Partner Login
  • Contact us
  • Site map
logo
  • About PRECISESADS
    • Project Structure
    • Project Governance
    • Expected Impact
  • Partners
  • News & Media
  • Events
  • Publications
  • Patients
    • Information for Patients
    • List of Patients associations
  • Useful links

Site map

  • Home
  •  
  • Site map

Páginas

  • About IMI
  • About PRECISESADS
    • Expected Impact
    • Project Governance
    • Project Structure
  • Access denied
  • Contact us
  • Cookie policy
  • Deliverables
  • Events
  • Home
  • News & Media
  • Page Not Found
  • Partner login
  • Partner Meetings
  • Partners
  • Patients
    • Information for Patients
    • List of Patients associations
  • Periodic Reports
  • Personal data
  • Project management
  • Publications
  • Request changes
  • Search template
  • Single features template
  • Single post template
  • Site map
  • Upload document
  • Useful links

Posts por categoría

  • Categoría: News
    • Milestone reached: 1000 participants recruited!!
    • PRECISESADS Steering Committee meeting, Granada - October 2015
    • Joint Legal & Ethical Workshop, Hannover - June 2015
    • Annual General Assembly Meeting - Berlin, Feb 2015
    • PRECISESADS & AETIONOMY Projects Joint Workshop
    • Launch of PRECISESADS in Spain - El Pais Interview
    • PRECISESADS Kick off meeting, Brussels, 18-19th February 2014
  • Categoría: Uncategorized
    • PRECISESADS Press Release

events

  • III European Conference “Genomics of Complex Diseases: New Challenges”
  • LUPUS 2015
  • EULAR 2015
  • International Congress of Autoimmunity
  • ACR Annual Meeting Boston
  • EULAR 2014

    • IMI
    • European Union
    • EFPIA

    This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.

    PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° [115565], resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

PRECISESADS

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases

  • P. T. Ciencias de la Salud Avda. de la Ilustración 114
    Telf. +34 958 715 500 (ext 202)
  • 18016 Granada, Spain
    Fax +34 958 637 071
  • [email protected]

Latest News

  • Milestone reached: 1000 participants recruited!! 2015-12-09T13:11:35+00:00
  • PRECISESADS Steering Committee meeting, Granada - October 2015 2015-10-27T12:21:05+00:00
  • Joint Legal & Ethical Workshop, Hannover - June 2015 2015-10-27T11:29:26+00:00
  • Cookie policy
  • Personal data
© Copyright - Precisesads. All rights reserved.
Top